Infinity Pharmaceuticals, Inc.
INFIQ · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $19 | $14 | $50 | $106 |
| - Cash | $18 | $26 | $38 | $47 |
| + Debt | $1 | $1 | $48 | $49 |
| Enterprise Value | $2 | -$11 | $59 | $108 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -20.2% | 34.6% | -23.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 39.6% | 39.7% | 39.8% | 24.2% |
| EBITDA | -$10 | -$11 | -$9 | -$11 |
| % Margin | -1,681.8% | -1,490.4% | -1,672% | -1,483.3% |
| Net Income | -$10 | -$11 | -$9 | -$11 |
| % Margin | -1,707.7% | -1,510.9% | -1,699.8% | -1,505.2% |
| EPS Diluted | -0.11 | -0.12 | -0.1 | -0.12 |
| % Growth | 8.3% | -20% | 16.7% | – |
| Operating Cash Flow | -$8 | -$13 | -$9 | -$9 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$8 | -$13 | -$9 | -$9 |